146 related articles for article (PubMed ID: 31190803)
41. One-step preparation of poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) nanoparticles for plasmid DNA delivery.
Huang MJ; Gou ML; Qian ZY; Dai M; Li XY; Cao M; Wang K; Zhao J; Yang JL; Lu Y; Tu MJ; Wei YQ
J Biomed Mater Res A; 2008 Sep; 86(4):979-86. PubMed ID: 18067161
[TBL] [Abstract][Full Text] [Related]
42. LHPP, a risk factor for major depressive disorder, regulates stress-induced depression-like behaviors through its histidine phosphatase activity.
Lin D; Li L; Chen WB; Chen J; Ren D; Zheng ZH; Zhao C; Zhong Y; Luo B; Jing H; Chen P; Zou S; Lai X; Zhou T; Ding N; Li L; Pan BX; Fei E
Mol Psychiatry; 2023 Feb; 28(2):908-918. PubMed ID: 36460727
[TBL] [Abstract][Full Text] [Related]
43. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
44. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
[TBL] [Abstract][Full Text] [Related]
45. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
46. Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles.
Jiang X; Xin H; Gu J; Du F; Feng C; Xie Y; Fang X
J Pharm Sci; 2014 May; 103(5):1487-96. PubMed ID: 24619482
[TBL] [Abstract][Full Text] [Related]
47. iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance.
Shen J; Meng Q; Sui H; Yin Q; Zhang Z; Yu H; Li Y
Mol Pharm; 2014 Aug; 11(8):2579-91. PubMed ID: 24236909
[TBL] [Abstract][Full Text] [Related]
48. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
49. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC
Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865
[TBL] [Abstract][Full Text] [Related]
50. Betulin silver nanoparticles qualify as efficient antimelanoma agents in in vitro and in vivo studies.
Danciu C; Pinzaru I; Coricovac D; Andrica F; Sizemore I; Dehelean C; Baderca F; Lazureanu V; Soica C; Mioc M; Radeke H
Eur J Pharm Biopharm; 2019 Jan; 134():1-19. PubMed ID: 30414497
[TBL] [Abstract][Full Text] [Related]
51. Poly(N-phenylglycine)-Based Nanoparticles as Highly Effective and Targeted Near-Infrared Photothermal Therapy/Photodynamic Therapeutic Agents for Malignant Melanoma.
Jiang BP; Zhang L; Guo XL; Shen XC; Wang Y; Zhu Y; Liang H
Small; 2017 Feb; 13(8):. PubMed ID: 27982516
[TBL] [Abstract][Full Text] [Related]
52. Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin.
Yu H; Chen J; Liu S; Lu Q; He J; Zhou Z; Hu Y
J Control Release; 2015 Oct; 216():111-20. PubMed ID: 26282096
[TBL] [Abstract][Full Text] [Related]
53. A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery.
Xu Y; Jin X; Ping Q; Cheng J; Sun M; Cao F; You W; Yuan D
J Control Release; 2010 Sep; 146(3):299-308. PubMed ID: 20580913
[TBL] [Abstract][Full Text] [Related]
54. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
55. Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis.
Zhou L; Duan X; Zeng S; Men K; Zhang X; Yang L; Li X
Int J Nanomedicine; 2015; 10():5205-18. PubMed ID: 26316750
[TBL] [Abstract][Full Text] [Related]
56. Targeted delivery of doxorubicin by nano-loaded mesenchymal stem cells for lung melanoma metastases therapy.
Zhao Y; Tang S; Guo J; Alahdal M; Cao S; Yang Z; Zhang F; Shen Y; Sun M; Mo R; Zong L; Jin L
Sci Rep; 2017 Mar; 7():44758. PubMed ID: 28303966
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy.
Kim J; Kang Y; Tzeng SY; Green JJ
Acta Biomater; 2016 Sep; 41():293-301. PubMed ID: 27262740
[TBL] [Abstract][Full Text] [Related]
58. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
[TBL] [Abstract][Full Text] [Related]
59. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.
Molavi O; Ma Z; Mahmud A; Alshamsan A; Samuel J; Lai R; Kwon GS; Lavasanifar A
Int J Pharm; 2008 Jan; 347(1-2):118-27. PubMed ID: 17681440
[TBL] [Abstract][Full Text] [Related]
60. Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells.
Shao J; Zheng D; Jiang Z; Xu H; Hu Y; Li X; Lu X
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):267-74. PubMed ID: 21349881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
